Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: Outcome and results of KRAS mutational analysis in plasma

Karen-Lise Garm Spindler, Morten Sørensen, Niels Pallisgaard, Rikke Andersen, Birgitte Mayland Havelund, John Ploen, Ulrik Lassen, Leif Anders Jakobsen

42 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: Outcome and results of KRAS mutational analysis in plasma'. Together they form a unique fingerprint.

Medicine & Life Sciences